Selected research
Industry Research
Nanopore Molecular Sequencing Service Industry Research Report 2026
Market perspective
The global Nanopore Molecular Sequencing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nanopore Molecular Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nanopore Molecular Sequencing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nanopore Molecular Sequencing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nanopore Molecular Sequencing Service include Azenta Life Sciences, Novogene Co., Ltd., BGI Genomics Co., Ltd., Eurofins Genomics, Plasmidsaurus, Biomarker Technologies Corporation, Macrogen Inc., CD Genomics and Microsynth AG, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nanopore Molecular Sequencing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nanopore Molecular Sequencing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nanopore Molecular Sequencing Service Market by Company
Azenta Life Sciences
Novogene Co., Ltd.
BGI Genomics Co., Ltd.
Eurofins Genomics
Plasmidsaurus
Biomarker Technologies Corporation
Macrogen Inc.
CD Genomics
Microsynth AG
BaseClear
Genotypic Technology Pvt. Ltd.
Takara Bio Inc.
FASMAC Co., Ltd.
SeqCenter
SeqCoast Genomics
Wuhan Benagen Tech Co., Ltd.
GenoScreen
IGA Technology
MicrobesNG
Source BioScience
GenXone
PathoSense
AllGenetics
BIOTOOLS Co., Ltd.
GeneBay, Inc.
Seibutsugiken Co., Ltd.
Biofidus
KeyGene
LongSeq Applications
Nanopore Molecular Sequencing Service Segment by Type
Direct DNA Sequencing
Direct RNA Sequencing
cDNA Sequencing (RNA→cDNA)
DNA+RNA Combined Sequencing
Nanopore Molecular Sequencing Service Segment by Application
Life Sciences
Clinical Medicine
Biomedicine
Public Health
Other
Nanopore Molecular Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanopore Molecular Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanopore Molecular Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanopore Molecular Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanopore Molecular Sequencing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct DNA Sequencing
- Direct RNA Sequencing
- cDNA Sequencing (RNA→cDNA)
- DNA+RNA Combined Sequencing
Applications
- Life Sciences
- Clinical Medicine
- Biomedicine
- Public Health
- Other
Companies covered
- Azenta Life Sciences
- Novogene Co., Ltd.
- BGI Genomics Co., Ltd.
- Eurofins Genomics
- Plasmidsaurus
- Biomarker Technologies Corporation
- Macrogen Inc.
- CD Genomics
- Microsynth AG
- BaseClear
- Genotypic Technology Pvt. Ltd.
- Takara Bio Inc.
- FASMAC Co., Ltd.
- SeqCenter
- SeqCoast Genomics
- Wuhan Benagen Tech Co., Ltd.
- GenoScreen
- IGA Technology
- MicrobesNG
- Source BioScience
- GenXone
- PathoSense
- AllGenetics
- BIOTOOLS Co., Ltd.
- GeneBay, Inc.
- Seibutsugiken Co., Ltd.
- Biofidus
- KeyGene
- LongSeq Applications
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nanopore Molecular Sequencing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Direct DNA Sequencing
- 2.2.3 Direct RNA Sequencing
- 2.2.4 cDNA Sequencing (RNA→cDNA)
- 2.2.5 DNA+RNA Combined Sequencing
- 2.3 Nanopore Molecular Sequencing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Life Sciences
- 2.3.3 Clinical Medicine
- 2.3.4 Biomedicine
- 2.3.5 Public Health
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Nanopore Molecular Sequencing Service Breakdown Data by Type
- 3.1 Global Nanopore Molecular Sequencing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Nanopore Molecular Sequencing Service Forecasted Market Size by Type (2027-2032)
4 Nanopore Molecular Sequencing Service Breakdown Data by Application
- 4.1 Global Nanopore Molecular Sequencing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Nanopore Molecular Sequencing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nanopore Molecular Sequencing Service Market Perspective (2021-2032)
- 5.2 Global Nanopore Molecular Sequencing Service Growth Trends by Region
- 5.2.1 Global Nanopore Molecular Sequencing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nanopore Molecular Sequencing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Nanopore Molecular Sequencing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Nanopore Molecular Sequencing Service Market Dynamics
- 5.3.1 Nanopore Molecular Sequencing Service Industry Trends
- 5.3.2 Nanopore Molecular Sequencing Service Market Drivers
- 5.3.3 Nanopore Molecular Sequencing Service Market Challenges
- 5.3.4 Nanopore Molecular Sequencing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nanopore Molecular Sequencing Service Players by Revenue
- 6.1.1 Global Top Nanopore Molecular Sequencing Service Players by Revenue (2021-2026)
- 6.1.2 Global Nanopore Molecular Sequencing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Nanopore Molecular Sequencing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nanopore Molecular Sequencing Service Head Office and Area Served
- 6.4 Global Nanopore Molecular Sequencing Service Players, Product Type & Application
- 6.5 Global Nanopore Molecular Sequencing Service Manufacturers Established Date
- 6.6 Global Nanopore Molecular Sequencing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nanopore Molecular Sequencing Service Market Size (2021-2032)
- 7.2 North America Nanopore Molecular Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nanopore Molecular Sequencing Service Market Size by Country (2021-2026)
- 7.4 North America Nanopore Molecular Sequencing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nanopore Molecular Sequencing Service Market Size (2021-2032)
- 8.2 Europe Nanopore Molecular Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nanopore Molecular Sequencing Service Market Size by Country (2021-2026)
- 8.4 Europe Nanopore Molecular Sequencing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nanopore Molecular Sequencing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Nanopore Molecular Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nanopore Molecular Sequencing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nanopore Molecular Sequencing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nanopore Molecular Sequencing Service Market Size (2021-2032)
- 10.2 South America Nanopore Molecular Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nanopore Molecular Sequencing Service Market Size by Country (2021-2026)
- 10.4 South America Nanopore Molecular Sequencing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nanopore Molecular Sequencing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Nanopore Molecular Sequencing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nanopore Molecular Sequencing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nanopore Molecular Sequencing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Azenta Life Sciences
- 12.1.1 Azenta Life Sciences Company Information
- 12.1.2 Azenta Life Sciences Business Overview
- 12.1.3 Azenta Life Sciences Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.1.4 Azenta Life Sciences Nanopore Molecular Sequencing Service Product Portfolio
- 12.1.5 Azenta Life Sciences Recent Developments
- 12.2 Novogene Co., Ltd.
- 12.2.1 Novogene Co., Ltd. Company Information
- 12.2.2 Novogene Co., Ltd. Business Overview
- 12.2.3 Novogene Co., Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.2.4 Novogene Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.2.5 Novogene Co., Ltd. Recent Developments
- 12.3 BGI Genomics Co., Ltd.
- 12.3.1 BGI Genomics Co., Ltd. Company Information
- 12.3.2 BGI Genomics Co., Ltd. Business Overview
- 12.3.3 BGI Genomics Co., Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.3.4 BGI Genomics Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.3.5 BGI Genomics Co., Ltd. Recent Developments
- 12.4 Eurofins Genomics
- 12.4.1 Eurofins Genomics Company Information
- 12.4.2 Eurofins Genomics Business Overview
- 12.4.3 Eurofins Genomics Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.4.4 Eurofins Genomics Nanopore Molecular Sequencing Service Product Portfolio
- 12.4.5 Eurofins Genomics Recent Developments
- 12.5 Plasmidsaurus
- 12.5.1 Plasmidsaurus Company Information
- 12.5.2 Plasmidsaurus Business Overview
- 12.5.3 Plasmidsaurus Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.5.4 Plasmidsaurus Nanopore Molecular Sequencing Service Product Portfolio
- 12.5.5 Plasmidsaurus Recent Developments
- 12.6 Biomarker Technologies Corporation
- 12.6.1 Biomarker Technologies Corporation Company Information
- 12.6.2 Biomarker Technologies Corporation Business Overview
- 12.6.3 Biomarker Technologies Corporation Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.6.4 Biomarker Technologies Corporation Nanopore Molecular Sequencing Service Product Portfolio
- 12.6.5 Biomarker Technologies Corporation Recent Developments
- 12.7 Macrogen Inc.
- 12.7.1 Macrogen Inc. Company Information
- 12.7.2 Macrogen Inc. Business Overview
- 12.7.3 Macrogen Inc. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.7.4 Macrogen Inc. Nanopore Molecular Sequencing Service Product Portfolio
- 12.7.5 Macrogen Inc. Recent Developments
- 12.8 CD Genomics
- 12.8.1 CD Genomics Company Information
- 12.8.2 CD Genomics Business Overview
- 12.8.3 CD Genomics Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.8.4 CD Genomics Nanopore Molecular Sequencing Service Product Portfolio
- 12.8.5 CD Genomics Recent Developments
- 12.9 Microsynth AG
- 12.9.1 Microsynth AG Company Information
- 12.9.2 Microsynth AG Business Overview
- 12.9.3 Microsynth AG Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.9.4 Microsynth AG Nanopore Molecular Sequencing Service Product Portfolio
- 12.9.5 Microsynth AG Recent Developments
- 12.10 BaseClear
- 12.10.1 BaseClear Company Information
- 12.10.2 BaseClear Business Overview
- 12.10.3 BaseClear Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.10.4 BaseClear Nanopore Molecular Sequencing Service Product Portfolio
- 12.10.5 BaseClear Recent Developments
- 12.11 Genotypic Technology Pvt. Ltd.
- 12.11.1 Genotypic Technology Pvt. Ltd. Company Information
- 12.11.2 Genotypic Technology Pvt. Ltd. Business Overview
- 12.11.3 Genotypic Technology Pvt. Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.11.4 Genotypic Technology Pvt. Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.11.5 Genotypic Technology Pvt. Ltd. Recent Developments
- 12.12 Takara Bio Inc.
- 12.12.1 Takara Bio Inc. Company Information
- 12.12.2 Takara Bio Inc. Business Overview
- 12.12.3 Takara Bio Inc. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.12.4 Takara Bio Inc. Nanopore Molecular Sequencing Service Product Portfolio
- 12.12.5 Takara Bio Inc. Recent Developments
- 12.13 FASMAC Co., Ltd.
- 12.13.1 FASMAC Co., Ltd. Company Information
- 12.13.2 FASMAC Co., Ltd. Business Overview
- 12.13.3 FASMAC Co., Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.13.4 FASMAC Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.13.5 FASMAC Co., Ltd. Recent Developments
- 12.14 SeqCenter
- 12.14.1 SeqCenter Company Information
- 12.14.2 SeqCenter Business Overview
- 12.14.3 SeqCenter Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.14.4 SeqCenter Nanopore Molecular Sequencing Service Product Portfolio
- 12.14.5 SeqCenter Recent Developments
- 12.15 SeqCoast Genomics
- 12.15.1 SeqCoast Genomics Company Information
- 12.15.2 SeqCoast Genomics Business Overview
- 12.15.3 SeqCoast Genomics Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.15.4 SeqCoast Genomics Nanopore Molecular Sequencing Service Product Portfolio
- 12.15.5 SeqCoast Genomics Recent Developments
- 12.16 Wuhan Benagen Tech Co., Ltd.
- 12.16.1 Wuhan Benagen Tech Co., Ltd. Company Information
- 12.16.2 Wuhan Benagen Tech Co., Ltd. Business Overview
- 12.16.3 Wuhan Benagen Tech Co., Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.16.4 Wuhan Benagen Tech Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.16.5 Wuhan Benagen Tech Co., Ltd. Recent Developments
- 12.17 GenoScreen
- 12.17.1 GenoScreen Company Information
- 12.17.2 GenoScreen Business Overview
- 12.17.3 GenoScreen Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.17.4 GenoScreen Nanopore Molecular Sequencing Service Product Portfolio
- 12.17.5 GenoScreen Recent Developments
- 12.18 IGA Technology
- 12.18.1 IGA Technology Company Information
- 12.18.2 IGA Technology Business Overview
- 12.18.3 IGA Technology Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.18.4 IGA Technology Nanopore Molecular Sequencing Service Product Portfolio
- 12.18.5 IGA Technology Recent Developments
- 12.19 MicrobesNG
- 12.19.1 MicrobesNG Company Information
- 12.19.2 MicrobesNG Business Overview
- 12.19.3 MicrobesNG Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.19.4 MicrobesNG Nanopore Molecular Sequencing Service Product Portfolio
- 12.19.5 MicrobesNG Recent Developments
- 12.20 Source BioScience
- 12.20.1 Source BioScience Company Information
- 12.20.2 Source BioScience Business Overview
- 12.20.3 Source BioScience Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.20.4 Source BioScience Nanopore Molecular Sequencing Service Product Portfolio
- 12.20.5 Source BioScience Recent Developments
- 12.21 GenXone
- 12.21.1 GenXone Company Information
- 12.21.2 GenXone Business Overview
- 12.21.3 GenXone Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.21.4 GenXone Nanopore Molecular Sequencing Service Product Portfolio
- 12.21.5 GenXone Recent Developments
- 12.22 PathoSense
- 12.22.1 PathoSense Company Information
- 12.22.2 PathoSense Business Overview
- 12.22.3 PathoSense Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.22.4 PathoSense Nanopore Molecular Sequencing Service Product Portfolio
- 12.22.5 PathoSense Recent Developments
- 12.23 AllGenetics
- 12.23.1 AllGenetics Company Information
- 12.23.2 AllGenetics Business Overview
- 12.23.3 AllGenetics Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.23.4 AllGenetics Nanopore Molecular Sequencing Service Product Portfolio
- 12.23.5 AllGenetics Recent Developments
- 12.24 BIOTOOLS Co., Ltd.
- 12.24.1 BIOTOOLS Co., Ltd. Company Information
- 12.24.2 BIOTOOLS Co., Ltd. Business Overview
- 12.24.3 BIOTOOLS Co., Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.24.4 BIOTOOLS Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.24.5 BIOTOOLS Co., Ltd. Recent Developments
- 12.25 GeneBay, Inc.
- 12.25.1 GeneBay, Inc. Company Information
- 12.25.2 GeneBay, Inc. Business Overview
- 12.25.3 GeneBay, Inc. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.25.4 GeneBay, Inc. Nanopore Molecular Sequencing Service Product Portfolio
- 12.25.5 GeneBay, Inc. Recent Developments
- 12.26 Seibutsugiken Co., Ltd.
- 12.26.1 Seibutsugiken Co., Ltd. Company Information
- 12.26.2 Seibutsugiken Co., Ltd. Business Overview
- 12.26.3 Seibutsugiken Co., Ltd. Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.26.4 Seibutsugiken Co., Ltd. Nanopore Molecular Sequencing Service Product Portfolio
- 12.26.5 Seibutsugiken Co., Ltd. Recent Developments
- 12.27 Biofidus
- 12.27.1 Biofidus Company Information
- 12.27.2 Biofidus Business Overview
- 12.27.3 Biofidus Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.27.4 Biofidus Nanopore Molecular Sequencing Service Product Portfolio
- 12.27.5 Biofidus Recent Developments
- 12.28 KeyGene
- 12.28.1 KeyGene Company Information
- 12.28.2 KeyGene Business Overview
- 12.28.3 KeyGene Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.28.4 KeyGene Nanopore Molecular Sequencing Service Product Portfolio
- 12.28.5 KeyGene Recent Developments
- 12.29 LongSeq Applications
- 12.29.1 LongSeq Applications Company Information
- 12.29.2 LongSeq Applications Business Overview
- 12.29.3 LongSeq Applications Revenue in Nanopore Molecular Sequencing Service Business (2021-2026)
- 12.29.4 LongSeq Applications Nanopore Molecular Sequencing Service Product Portfolio
- 12.29.5 LongSeq Applications Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst